Classification Models of Estrogen Receptor-B Ligands Based on PSO-Adaboost-SVM

In this paper, some chemometrics methods have been applied for modeling and predicting classification of Estrogen Receptor-β (ERβ) selective ligands derivatives with radial distribution function (RDF) descriptor calculated from the molecular structure alone for the first time. The particle swarm optimization (PSO) and genetic algorithms (GA) methods have been used to select descriptors which are responsible for the inhibitory activity of these compounds. Mathematical models are obtained by support vector machine (SVM) and Adaptive boosting (Adaboost). The model containing five descriptors founded by Adaboost-SVM has shown better predictive ability than the other models. The total accuracy in prediction for the training and test set are 100.0% and 94.3% for PSO-Adaboost-SVM, 98.0% and 91.4% for PSO-SVM, 100.0% and 88.6% for GA-Adaboost-SVM, 100.0% and 85.7% for GA-SVM, respectively. A comparison with other approaches such as Constitutional, Geometrical, 3D-MoRSE (3D-Molecular Representation of Structure based on Electron diffraction),Topological,GETAWAY(Geometry, Topological and Atoms-Weighted AssemblY) and 2D autocorrelations descriptors has also been carried out.

[1]  Riccardo Poli,et al.  Particle swarm optimization , 1995, Swarm Intelligence.

[2]  O. Deeb,et al.  Effect of the electronic and physicochemical parameters on the carcinogenesis activity of some sulfa drugs using QSAR analysis based on genetic-MLR and genetic-PLS. , 2007, Chemosphere.

[3]  Xu Shen,et al.  Aza analogues of equol: novel ligands for estrogen receptor beta. , 2007, Bioorganic & medicinal chemistry.

[4]  Yanrong Ren,et al.  Pseudo receptor probes: A novel pseudo receptor-based QSAR method and application into studies on a new kind of selective vascular endothelial growth factor-2 receptor inhibitors , 2008 .

[5]  M Carlquist,et al.  Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.

[6]  Wolfgang Sippl,et al.  Receptor-based 3D QSAR analysis of estrogen receptor ligands – merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods , 2000, J. Comput. Aided Mol. Des..

[7]  David H. Kaufman,et al.  7-Substituted 2-phenyl-benzofurans as ERβ selective ligands , 2004 .

[8]  C. Hansch,et al.  Comparative QSAR analysis of estrogen receptor ligands. , 1999, Chemical reviews.

[9]  Yoav Freund,et al.  A decision-theoretic generalization of on-line learning and an application to boosting , 1997, EuroCOLT.

[10]  J. Gustafsson,et al.  Cloning of a novel estrogen receptor expressed in rat prostate and ovary , 2022 .

[11]  L. Moore,et al.  A new series of estrogen receptor modulators that display selectivity for estrogen receptor beta. , 2002, Journal of medicinal chemistry.

[12]  R. Wilkening.  The Discovery of Tetrahydrofluorenones as a New Class of Estrogen Receptor β-Subtype Selective Ligands. , 2006 .

[13]  Mauro Birattari,et al.  Swarm Intelligence , 2012, Lecture Notes in Computer Science.

[14]  M. N. Vrahatis,et al.  Computing Nash equilibria through computational intelligence methods , 2005 .

[15]  J. V. Turner,et al.  Molecular structural characteristics as determinants of estrogen receptor selectivity. , 2008, Journal of pharmaceutical and biomedical analysis.

[16]  Iwan Gunawan,et al.  Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. , 2004, Journal of medicinal chemistry.

[17]  Peter Wolohan,et al.  CoMFA and docking study of novel estrogen receptor subtype selective ligands , 2003, J. Comput. Aided Mol. Des..

[18]  B. Zhu,et al.  Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding. , 2006, Endocrinology.

[19]  Nam Ik Cho,et al.  Automatic defect classification using boosting , 2005, Fourth International Conference on Machine Learning and Applications (ICMLA'05).

[20]  M. Cronin,et al.  Application of the modelling power approach to variable subset selection for GA-PLS QSAR models. , 2008, Analytica chimica acta.

[21]  B. Katzenellenbogen,et al.  Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. , 2001, Journal of medicinal chemistry.

[22]  Yoav Freund,et al.  A decision-theoretic generalization of on-line learning and an application to boosting , 1995, EuroCOLT.

[23]  P. Argos,et al.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A , 1986, Nature.

[24]  J. Friedman.  Special Invited Paper-Additive logistic regression: A statistical view of boosting , 2000 .

[25]  Jon G. Wilkes,et al.  Use of 13C NMR Spectrometric Data To Produce a Predictive Model of Estrogen Receptor Binding Activity , 2001, J. Chem. Inf. Comput. Sci..

[26]  Yue Shi,et al.  A modified particle swarm optimizer , 1998, 1998 IEEE International Conference on Evolutionary Computation Proceedings. IEEE World Congress on Computational Intelligence (Cat. No.98TH8360).

[27]  B. Katzenellenbogen,et al.  Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. , 2002, Endocrinology.

[28]  U. Schopfer,et al.  Toward selective ERbeta agonists for central nervous system disorders: synthesis and characterization of aryl benzthiophenes. , 2002, Journal of medicinal chemistry.

[29]  Maykel Pérez González,et al.  Modeling of farnesyltransferase inhibition by some thiol and non-thiol peptidomimetic inhibitors using genetic neural networks and RDF approaches. , 2006, Bioorganic & medicinal chemistry.

[30]  Riccardo Leardi,et al.  Application of genetic algorithm–PLS for feature selection in spectral data sets , 2000 .

[31]  B. Fan,et al.  Classification of estrogen receptor-beta ligands on the basis of their binding affinities using support vector machine and linear discriminant analysis. , 2008, European journal of medicinal chemistry.

[32]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[33]  B. Komm,et al.  Regulation of Metallothionein II Messenger Ribonucleic Acid Measures Exogenous Estrogen Receptor-β Activity in SAOS-2 and LNCaPLN3 Cells. , 2001, Endocrinology.

[34]  B. Katzenellenbogen,et al.  Characterization of the Biological Roles of the Estrogen Receptors, ERα and ERβ, in Estrogen Target Tissues in Vivo through the Use of an ERα-Selective Ligand , 2002 .

[35]  Ali M. S. Zalzala,et al.  Recent developments in evolutionary and genetic algorithms: theory and applications , 1997 .

[36]  Elaine F. F. da Cunha,et al.  LIV-3D-QSAR model for estrogen receptor ligands , 2004 .

[37]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  W S Branham,et al.  Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: predictions across species. , 1997, Environmental health perspectives.

[39]  E. Benfenati,et al.  Structural features of diverse ligands influencing binding affinities to Estrogen α and Estrogen β receptors. Part I: molecular descriptors calculated from minimal energy conformation of isolated ligands , 2007, Molecular Diversity.

[40]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[41]  R. Chesworth.  Estrogen Receptor β Selective Ligands: Discovery and SAR of Novel Heterocyclic Ligands. , 2006 .

[42]  Maykel Pérez González,et al.  Radial distribution function descriptors: an alternative for predicting A2 A adenosine receptors agonists. , 2006, European journal of medicinal chemistry.

[43]  Emilio Benfenati,et al.  Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors alpha and beta by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis. , 2005, Journal of medicinal chemistry.

[44]  B. Fournier,et al.  Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands. , 2003, Journal of medicinal chemistry.

[45]  Menghui H. Zhang,et al.  Application of boosting to classification problems in chemometrics , 2005 .

[46]  Maykel Pérez González,et al.  In silico studies using Radial Distribution Function approach for predicting affinity of 1α,25-dihydroxyvitamin D3 analogues for Vitamin D receptor , 2006, Steroids.